Trademark Overview
On Wednesday, September 6, 2023, a trademark application was filed for PHAROS IBIO with the United States Patent and Trademark Office. The USPTO has given the PHAROS IBIO trademark a serial number of 79386772. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, April 11, 2024. This trademark is owned by Pharos iBio Co., Ltd.. The PHAROS IBIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; reagents and media for medical and veterinary diagnostic purposes; medicinal healthcare preparations; pharmaceutical drugs; diagnostic agents for pharmaceutical use; medicinal creams; synthetic peptides for pharmaceutical purposes; chemical preparations for pharmaceutical purposes; pharmaceutical compositions; pharmaceuticals; human vaccine preparations; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of immune system related diseases and disorders; nutraceuticals for therapeutic purposes; therapeutic drugs and agents; anti-cancer preparations
Scientific research conducted using databases; research and development of vaccines and medicines; analysis in the field of molecular biology; development of computer software for big data processing; research and development of technology for biotechnology; consultancy in the field of biotechnology; research relating to biotechnology; advisory services relating to biotechnology; biotechnology services; biological information check (genetic testing for scientific research purposes); biological information check (genetic testing for medical research purposes); platform as a service [PaaS]; development of cell therapy products; development, updating and maintenance of software and database systems; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; consultancy relating to research in the field of pharmacogenetics; research in the field of pharmacogenetics; pharma...
